My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
December 2014
Policy and Advocacy
New Law to Incentivize Ebola Drug Development

The House and Senate both passed the IDSA-supported legislation that will add Ebola to the FDA Priority Review Voucher program, to help incentivize development of new drugs to treat Ebola. The bill is headed to the President for his signature.



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
CDC Warns of Drifted Influenza A H3N2 Viruses
Clinical Practice Management
The Future of Telemedicine in ID
Policy and Advocacy
Fiscal Year 2015 Brings Stagnant Funding for ID, HIV
New Law to Incentivize Ebola Drug Development
Global ID
Science Speaks
Education and Resources
IDSA In-Training Exam is a Good Predicator of Performance on ID Certification Exam
IDSA Offers New MOC Modules on General ID and Infection Control
You and Your Colleagues
New Members
Top Stories
From the President: My Membership in IDSA is Part of My Identity as an ID Physician
Progress Continues on Several Antimicrobial Resistance Advocacy Fronts
IDSA Ebola Grants Still Available
Medical Scholars Program Applications Accepted Now Through February 2
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.